Related Experiment Video
Updated: Jul 16, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Thromboembolic complications in beta-thalassemia: Beyond the horizon
Inusha Panigrahi1, Sarita Agarwal
1Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh-12, India. inupan@yahoo.com
Abstract:
Patients with beta-thalassemia have a chronic hypercoagulable state with increased incidence of thromboembolic episodes. The thrombotic complications are more common in thalassemia intermedia than in regularly transfused thalassemia major. The pathophysiologic defects include inherent red cell defects, platelet abnormalities, deficiency of coagulation inhibitors, and additional acquired abnormalities like cardiac and liver dysfunction, hormonal deficiencies. These factors and possible preventive measures are discussed in this review. An illustrative case is also presented.
Related Concept Videos
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
